Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 80 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Phone269-389-2600
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$13.60 billion
Profitability
Miscellaneous
Employees36,000
Next Earnings Date7/23/2019 (Estimated)
OptionableOptionable
Stryker (NYSE:SYK) Frequently Asked Questions
What is Stryker's stock symbol?
Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."
How often does Stryker pay dividends? What is the dividend yield for Stryker?
Stryker announced a quarterly dividend on Wednesday, May 1st. Investors of record on Friday, June 28th will be paid a dividend of $0.52 per share on Wednesday, July 31st. This represents a $2.08 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend is Thursday, June 27th. View Stryker's Dividend History.
How were Stryker's earnings last quarter?
Stryker Co. (NYSE:SYK) issued its quarterly earnings data on Tuesday, April, 23rd. The medical technology company reported $1.88 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.84 by $0.04. The medical technology company had revenue of $3.52 billion for the quarter, compared to analyst estimates of $3.51 billion. Stryker had a return on equity of 26.72% and a net margin of 25.38%. The business's revenue was up 8.5% on a year-over-year basis. During the same quarter last year, the business earned $1.68 EPS. View Stryker's Earnings History.
When is Stryker's next earnings date?
What guidance has Stryker issued on next quarter's earnings?
Stryker updated its FY19 earnings guidance on Tuesday, April, 23rd. The company provided earnings per share (EPS) guidance of $8.05-8.20 for the period, compared to the Thomson Reuters consensus estimate of $8.13. Stryker also updated its FY 2019 guidance to $8.05-8.20 EPS.
What price target have analysts set for SYK?
21 analysts have issued 1 year target prices for Stryker's stock. Their predictions range from $156.75 to $219.00. On average, they expect Stryker's share price to reach $196.2875 in the next year. This suggests a possible upside of 6.4% from the stock's current price. View Analyst Price Targets for Stryker.
What is the consensus analysts' recommendation for Stryker?
21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 6 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stryker.
Has Stryker been receiving favorable news coverage?
Press coverage about SYK stock has been trending negative this week, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Stryker earned a daily sentiment score of -2.7 on InfoTrie's scale. They also assigned news articles about the medical technology company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the immediate future.
Who are some of Stryker's key competitors?
Some companies that are related to Stryker include 3M (MMM), Becton Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), Teleflex (TFX), ABIOMED (ABMD), DexCom (DXCM), Hill-Rom (HRC), Insulet (PODD), Haemonetics (HAE), Penumbra (PEN), Novocure (NVCR) and ICU Medical (ICUI).
What other stocks do shareholders of Stryker own?
Who are Stryker's key executives?
Stryker's management team includes the folowing people:
- Mr. Kevin A. Lobo, Chairman & CEO (Age 54)
- Mr. Timothy J. Scannell, Pres & COO (Age 54)
- Mr. Glenn S. Boehnlein, VP & CFO (Age 57)
- Mr. Michael D. Hutchinson, VP & Chief Legal Officer (Age 48)
- Mr. Lonny J. Carpenter, Group Pres & Adviser to the CEO (Age 57)
Who are Stryker's major shareholders?
Stryker's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.71%), Greenleaf Trust (5.96%), FMR LLC (1.80%), Fundsmith LLP (1.50%), Northern Trust Corp (1.05%) and Geode Capital Management LLC (1.04%). Company insiders that own Stryker stock include Bijoy Sagar, David Floyd, Glenn S Boehnlein, Graham A Mclean, Howard E Cox Jr, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Timothy J Scannell, William E Berry Jr and Yin C Becker. View Institutional Ownership Trends for Stryker.
Which institutional investors are selling Stryker stock?
SYK stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Greenleaf Trust, Lazard Asset Management LLC, California Public Employees Retirement System, AQR Capital Management LLC, Janus Henderson Group PLC, Pictet Asset Management Ltd. and Westpac Banking Corp. Company insiders that have sold Stryker company stock in the last year include Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Timothy J Scannell and Yin C Becker. View Insider Buying and Selling for Stryker.
Which institutional investors are buying Stryker stock?
SYK stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Ellis Investment Partners LLC, Geode Capital Management LLC, GQG Partners LLC, State Treasurer State of Michigan, Teacher Retirement System of Texas, BlackRock Inc. and Ferguson Wellman Capital Management Inc.. View Insider Buying and Selling for Stryker.
How do I buy shares of Stryker?
Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Stryker's stock price today?
One share of SYK stock can currently be purchased for approximately $184.50.
How big of a company is Stryker?
Stryker has a market capitalization of $68.84 billion and generates $13.60 billion in revenue each year. The medical technology company earns $3.55 billion in net income (profit) each year or $7.31 on an earnings per share basis. Stryker employs 36,000 workers across the globe.
What is Stryker's official website?
How can I contact Stryker?
Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]
MarketBeat Community Rating for Stryker (NYSE SYK)
MarketBeat's community ratings are surveys of what our community members think about Stryker and other stocks. Vote "Outperform" if you believe SYK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SYK will underperform the S&P 500 over the long term. You may vote once every thirty days.
